RE:RE:RE:RE:RE:RE:What happened to radachlorin pdt for NMIBC?I appreciate all your contributions SF. However UHN undertreating the first 12 patients of PH2 has set this company back at least 2 years and that was after they successfully applied the so called optimized procedure to patients 4~6 in PH1. After that tremendous FU I would never recommend anyone get treated at UHN PMCC.. I don't have years and years to piss away unlike the rest of the board members. (sarcasm)
ScienceFirst wrote: We have to give credit to TLT that does everything by the book and never cut corners when it comes to what the FDA/HC/EU require in terms of papers and rigorous standards.
By teaming up with UHN and PMCC, we were sure to never have a flawed study. TOOKAD and Radachlorin seem to have taken a shorted route that lead them nowhere. That's usually what happen when you cut corners.
I remember some clown investors back in 2015 asking TLT to do it's Ph. 1b in an airplane or on an ship in international waters so it could get around the rigorous FDA/HC requirements! It's unbelievable that clowns we have on internet, thinking they know things should be done! lollll